Here is a full analysis of Yash's report and targeted treatment guidance.
Report Summary - Dr. Yash Pathak (Male, 28 yrs) | 13 March 2026
Key Findings at a Glance
| Test | Result | Reference Range | Status |
|---|
| TSH | 11.894 µIU/mL | 0.38 - 5.33 | 🔴 HIGH |
| Free T3 | 3.15 pg/mL | 2.5 - 3.9 | ✅ Normal |
| Free T4 | 0.89 ng/dL | 0.61 - 1.12 | ✅ Normal |
| Anti-TPO | 0.7 IU/mL | <9.0 | ✅ Normal |
| Vitamin B12 | 188 pg/mL | 211 - 911 | 🔴 LOW |
| WBC | 11,270 /cmm | 4000 - 10,000 | 🟡 Slightly elevated |
| Absolute Lymphocytes | 4,170 /cmm | 1000 - 3,900 | 🟡 Slightly elevated |
| G6PD | 12.69 U/g Hb | 7.0 - 20.5 | ✅ Normal |
Interpretation
1. Subclinical Hypothyroidism
TSH is 11.894 µIU/mL (more than double the upper limit of 5.33), while Free T3 and Free T4 are both within normal range. This pattern is classic subclinical (compensated) hypothyroidism - the thyroid gland is underperforming, but the pituitary is compensating by secreting extra TSH, maintaining normal thyroid hormone levels for now.
Anti-TPO is negative (0.7 IU/mL), which means this is not autoimmune (Hashimoto's) thyroiditis at this point.
2. Vitamin B12 Deficiency
B12 at 188 pg/mL is below the lower limit of 211 pg/mL. This is a borderline-to-low B12 that warrants supplementation. Note the CBC shows no macrocytic anemia yet (MCV 82.7 - actually slightly microcytic/borderline), but neurological symptoms can precede hematological changes.
3. WBC/Lymphocyte Elevation
Mild lymphocytosis (ALC 4170 vs. upper limit 3900) - likely reactive, possibly from an intercurrent viral illness. Not alarming in isolation.
Treatment of Elevated TSH (Subclinical Hypothyroidism)
Decision to Treat
Per the evidence from Rosen's Emergency Medicine and Katzung's Pharmacology:
Levothyroxine is the drug of choice for subclinical hypothyroidism when TSH is above 10 mIU/L - Rosen's Emergency Medicine, p. 2572
Since Yash's TSH (11.894) exceeds 10 µIU/mL, treatment is clearly indicated even without symptoms.
Levothyroxine (LT4) - Drug of Choice
| Parameter | Details |
|---|
| Drug | Levothyroxine (L-thyroxine / T4) |
| Starting dose | 50-75 µg/day (typical for subclinical hypothyroidism in young adults) |
| Weight-based dose | ~1.6 µg/kg/day for overt hypothyroidism; start lower for subclinical |
| Administration | Take on an empty stomach - 60 minutes before breakfast, OR at bedtime |
| Monitoring | Recheck TSH every 6-8 weeks after starting until levels normalize |
| Target TSH | 0.5 - 2.5 µIU/mL (within normal range for a 28-year-old) |
Why NOT Combination T3+T4?
Studies comparing combination LT4 + liothyronine (T3) vs. LT4 alone have not shown significant benefit for most patients. Levothyroxine monotherapy remains standard - Rosen's Emergency Medicine, p. 2572.
Absorption Precautions
Several medications and supplements reduce levothyroxine absorption - take LT4 at least 4 hours apart from:
- Calcium supplements
- Iron supplements (important since B12 treatment may be started simultaneously)
- Antacids (PPIs, sucralfate)
- Cholestyramine
Treatment of Vitamin B12 Deficiency
Since B12 is low but the patient is young and likely has dietary deficiency (meat/egg/dairy intake), oral supplementation is a reasonable first step unless absorption is suspected to be impaired:
- Oral B12 (cyanocobalamin or methylcobalamin): 500-1000 µg/day orally
- IM B12 option: If dietary cause is unlikely or neurological symptoms present - cyanocobalamin 1000 µg IM weekly x 4 weeks, then monthly
- Recheck B12 levels in 3 months
Follow-Up Plan
- Start Levothyroxine 50 µg/day (can titrate up to 75 µg after 6-8 weeks based on TSH response)
- Repeat TSH + Free T4 in 6-8 weeks
- Start B12 supplementation (oral or IM per clinical judgment)
- Recheck B12 in 3 months
- CBC repeat in 4-6 weeks to ensure lymphocytosis resolves
- If TSH remains elevated on repeat, consider checking Anti-TPO again in 6-12 months (some patients develop autoimmune thyroiditis over time)
Disclaimer: This analysis is for educational/clinical support purposes. Final treatment decisions must be made by the treating physician (Dr. Kishor H. Sheth in this case), taking into account the full clinical picture, symptoms, and patient history.